Pelthos Therapeutics Establishes Board of Directors
Pelthos Therapeutics (Pelthos), a biopharmaceutical company committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens, today announced it has appointed five seasoned industry professionals to serve on its Board of Directors.
- Pelthos Therapeutics (Pelthos), a biopharmaceutical company committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens, today announced it has appointed five seasoned industry professionals to serve on its Board of Directors.
- “These directors bring deep operational, clinical and commercialization experience to Pelthos as we approach an important inflection point,” said Scott Plesha, CEO of Pelthos.
- He is also a member of the Board of Directors at Soleno Therapeutics and Amplo Biotechnology.
- In addition, Mr. Pauls previously served as Chair of the Board of Directors of Mast Therapeutics and was a member of the Board of Directors of Zyla Life Sciences.